Anti-inflammatory and Antioxidative Activities of Safranal in the Reduction of Renal Dysfunction and Damage that Occur in Diabetic Nephropathy

Inflammation

Volumn 38, Issue 4, 2015, Pages 1537-1545

  Hazman, Ömer ^a   Bozkurt, Mehmet Fatih ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

diabetic nephropathy; inflammation; oxidative stress; safranal

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CREATININE; GAMMA INTERFERON; GLUTATHIONE; HERBACEOUS AGENT; INTERLEUKIN 18; INTERLEUKIN 1BETA; NITRIC OXIDE; SAFRANAL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYCLOHEXENE DERIVATIVE; TERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY INJURY; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; ANIMAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CYCLOHEXENES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; KIDNEY; MALE; RATS; RATS, WISTAR; TERPENES;

EID: 84937252255     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0128-y     Document Type: Article

References (35)

1. ADA (American Diabetes Association). 2014. Diagnosis and classification of diabetes mellitus. Diabetes Care 37(1): S81–S90.
2. IDF (International Diabetes Fedaration). 2014. IDF Diabetes Atlas, 6 edition, p 12.
3. Duran-Salgado, M.B., and A.F. Rubio-Guerra. 2014. Diabetic nephropathy and inflammation. World Journal of Diabetes 5(3): 393–398.
4. Hazman, Ö., and S. Çelik. 2014. Effects of oral anti-diabetic agent sitagliptin on total antioxidant and oxidant status in rats with type 2 diabetes mellitus. Journal of Applied Biological Sciences 8(1): 31–37.
5. Elmarakby, A.A., and J.C. Sullivan. 2012. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular Therapeutics 30: 49–59.
6. Elbe H., N. Vardi, M. Esrefoglu, B. Ates, S. Yologlu and C. Taskapan. 2014. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Human and Experimental Toxicology: 1–14. DOI: 10.1177/0960327114531995.
7. Hasegawa, G., K. Nakano, and M. Kondo. 1995. Role of TNF and IL-1 in the development of diabetic nephropathy. Nefrología 15: 1–4.
8. Navarro-Gonzalez, J.F., and C. Mora-Fernandez. 2008. The role of inflammatory cytokines in diabetic nephropathy. Journal of the American Society of Nephrology 19: 433–442.
9. García-García, P.M., M.A. Getino-Melián, V. Domínguez-Pimentel, and J.F. Navarro-González. 2014. Inflammation in diabetic kidney disease. World Journal of Diabetes 5(4): 431–443.
10. Assimopoulou, A.N., Z. Sinakos, and V.P. Papageorgiou. 2005. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytotherpahy Research 19: 997–1000.
11. Samarghandian, S., R. Afshari, A. Sadati. 2014. Evaluation of lung and bronchoalveolar lavage fluid oxidative stress indices for assessing the preventing effects of safranal on respiratory distress in diabetic rats. The Scientific World Journal, Article ID 251378, 6. http://dx.doi.org/10.1155/251378.
12. Hazman, O., and S. Ovalı. 2014. Investigation of the anti-inflammatory effects of safranal on high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Inflammation. doi:10.1007/s10753-014-0065-1.
13. Kainbakht, S., and R. Hajiaghaee. 2011. Anti-hyperglycemic effects of saffron and its active constituents, crocin and safranal, in alloxan-induced diabetic rats. Journal of Medicinal Plant 10(39): 82–89.
14. Escribano, J., G.L. Alonso, M. Coca-Prados, and J.A. Fernandez. 1996. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Letters 100: 23–30.
15. Imenshahidi, M., H. Hosseinzadeh, and Y. Javadpour. 2010. Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytotherapy Research 24(7): 990–994.
16. Zhang, M., M.Y. Lv, J. Lı, Z.G. Xu, L. Chen. 2008. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Experimental Diabetes Research, Article ID 704045, 1–9.
17. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 7(72): 248–254.
18. Erel, Ö. 2004. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 37(2): 112–119.
19. Erel, Ö. 2005. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 38(12): 1103–1111.
20. Miranda, K.M., M.G. Espey, and D.A. Wink. 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5: 62–71.
21. Elman, G.L. 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82: 70–77.
22. Amin, K.A., H.H. Kamel, and M.A. Eltawab. 2011. Protective effect of Garcinia against renal oxidative stress and biomarkers induced by high fat and sucrose diet. Lipids in Health and Disease 10(6): 1–13.
23. Kim, C.M., S.J. Yi, I.J. Cho, and S.K. Ku. 2013. Red-Koji fermented red ginseng ameliorates high fat diet-induced metabolic disorders in mice. Nutrients 5: 4316–4332.
24. Gai, Z., C. Hiller, S.H. Chin, L. Hofstetter, B. Stieger, D. Konrad, and G.A. Kullak-Ublick. 2014. Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney. Biochimica et Biophysica Acta 1842: 1870–1878.
25. Altinoz, E., Z. Oner, H. Elbe, Y. Cigremis, and Y. Turkoz. 2014. Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats. Human and Experimental Toxicology. doi:10.1177/0960327114538989.
26. Sekizuka, K., Y. Tomino, C. Sei, A. Kurusu, K. Tashiro, Y. Yamaguchi, S. Kodera, T. Hishiki, I. Shirato, and H. Koide. 1994. Detection of serum IL-6 in patients with diabetic nephropathy. Nephron 68: 284–285.
27. Sassy-Prigent, C., D. Heudes, S. Jouquey, D. Auberval, M.F. Belair, O. Michel, G. Hamon, J. Bariety, and P. Bruneval. 2000. Early glomerular macrophage recruitment in streptozotocin induced diabetic rats. Diabetes 49: 466–475.
28. Moriwaki, Y., T. Yamamoto, Y. Shibutani, E. Aoki, Z. Tsutsumi, S. Takahashi, H. Okamura, M. Koga, M. Fukuchi, and T. Hada. 2003. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52: 605–608.
29. Nosratabadi, R., M.K. Arababadi, G. Hassanshahi, N. Yaghini, V. Pooladvand, A. Shamsizadeh, E.R. Zarandi, and H. Hakimi. 2009. Evaluation of IFN-gamma serum level in nephropatic type 2 diabetic patients. Pakistan Journal of Biological Sciences 12(9): 746–749.
30. Mallamaci, F., and G. Tripepi. 2013. Obesity and CKD progression: hard facts on fat CKD patients. Nephrology, Dialysis, Transplantation 28(4): iv105–iv108.
31. Börgeson, E., and K. Sharma. 2013. Obesity, immunomodulation and chronic kidney disease. Current Opinion in Pharmacology 13: 618–624.
32. Ma, L.J., B.A. Corsa, J. Zhou, H. Yang, H. Li, Y.W. Tang, V.R. Babaev, A.S. Major, M.F. Linton, S. Fazio, T.E. Hunley, V. Kon, and A.B. Fogo. 2011. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. American Journal of Physiology. Renal Physiology 300: F1203–F1213.
33. Fronczyk, A., P. Molęda, K. Safranow, W. Piechota, and L. Majkowska. 2014. Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control. Inflammation 37(2): 349–357.
34. Jeong, K.H., T.W. Lee, C.G. Ihm, S.H. Lee, J.Y. Moon, and S.J. Lim. 2009. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. American Journal of Nephrology 29: 274–282.
35. Noeman, S.A., H.E. Hamooda, and A.A. Baalash. 2011. Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetology and Metabolic Syndrome 3: 17.